IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)

Recruiting now

Conditions studied: Ischemic Stroke, Thrombectomy

In brief

IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the possible impact of these profiles on the functional prognosis at 3 and 12 months of AIC treatment.

Key facts

Study ID

NCT04663399

Run by

Fondation Ophtalmologique Adolphe de Rothschild

People needed

1200

Starts

2023-02-23

Expected to finish

2028-05-23

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with an acute ischemic stroke for which treatment with mechanical thrombectomy is indicated, whether or not thrombectomy is performed,
• Having received informed information about the study and having signed a consent to participate in the study (if this is not possible: information and consent of the trusted support person or family member if present; emergency inclusion if absent);
• Affiliated or beneficiary of a social security scheme or equivalent.
• Non inclusion Criteria:
• Pregnant or breast-feeding women
• Patient benefiting from a legal protection measure

You may not qualify if…

• None.

Where it is running

• Hôpital Fondation Adolphe de Rothschild — Paris, Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.